Related Experiment Video
Updated: Aug 7, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
[Digitalis intoxication secondary to treatment with clarithromycin]
M Bonilla Porras1, M A Lucena Campillo, E Delgado Silveira
1Servicio de Farmacia, Hospital Severo Ochoa, Leganés, Madrid, Spain. macabonilla@hotmail.com
Concurrent use of digoxin and clarithromycin can lead to elevated serum digoxin concentrations and digitalis intoxication. Monitoring digoxin levels in patients receiving clarithromycin is recommended to prevent adverse events.
Area of Science:
- Pharmacology
- Clinical Pharmacy
Background:
- Digoxin is a cardiac glycoside used for heart failure and arrhythmias.
- Clarithromycin is a macrolide antibiotic with known drug interaction potential.
Observation:
- This retrospective study analyzed inpatients receiving both digoxin and clarithromycin.
- Serum digoxin concentrations were monitored to assess potential drug interactions.
Findings:
- 11.5% of patients on concurrent digoxin and clarithromycin showed supratherapeutic digoxin levels.
- Three patients experienced digitalis intoxication, likely due to the drug interaction.
- Inadequate dosing or insufficient interaction time accounted for other cases of elevated levels.
Implications:
- Concurrent administration of digoxin and clarithromycin necessitates careful monitoring of serum digoxin concentrations.
- This interaction poses a risk of digitalis toxicity, requiring clinical vigilance.
- Pharmacists and clinicians should be aware of this interaction to ensure patient safety.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Drug–Drug Interaction
Myocarditis III: Medical Management